Oxford BioMedica
Employee Participants0
Total Rating0
Revenue$0
Developer of a gene and cell therapy company focused on developing life changing treatments for serious diseases. The company's platform builds exclusive cutting-edge technologies and capabilities, based on a sector leading and proprietary single dose gene therapy platform LentiVector with which they design, develop and produce gene and cell based medicines for themselves and their partners in the areas of oncology, ophthalmology and CNS disorders. Read More
Headquarters Windrush Court, Oxford, OX4 6LT, GBR
Website www.oxfordbiomedica.co.uk
0/100